Clinical pharmacology of non-steroidal anti-inflammatory drugs: novel acquisitions

  • A. Sala
  • R. Ballerio
  • S. Viappiani
  • S. Zarini
Part of the Topics in Anaesthesia and Critical Care book series (TIACC)


Prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and hydroxyeicosatetraenoic acids (HETEs) are collectively referred to as eicosanoids because they are derived from 20-carbon essential fatty acids that contain three, four or five double bonds (i.e. 8, 11, 14-eicosatrienoic acid, 5, 8, 11, 14-eicosatetraenoic acid or arachidonic acid and 5, 8, 11, 14, 17-eicosapentaenoic acid). In humans, arachidonic acid represents the most abundant percursor.


Arachidonic Acid Arachidonic Acid Metabolism Hydroxyeicosatetraenoic Acid Unesterified Arachidonic Acid Icosatetraenoic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dennis EA (1994) Diversity of group types, regulation and function of phospholipase A2. J Biol Chem 269: 13057–13060PubMedGoogle Scholar
  2. 2.
    Smith WL, Garavito RM, DeWitt DL (1996) Prostaglandin endoperoxide H synthases (ciclooxygenases)-1 and -2. J Biol Chem 271: 33157–33160PubMedCrossRefGoogle Scholar
  3. 3.
    Back SJ, Lee K-D, Shen R-F (1996) Genomic structure and polymorphism of the human thromboxane synthase-encoding gene. Gene 173: 251–256CrossRefGoogle Scholar
  4. 4.
    Wang L-H, Chen L (1996) Organization of the gene encoding human prostacyclin synthase. Biochem Biophys Res Commun 226: 631–637PubMedCrossRefGoogle Scholar
  5. 5.
    Nakayama T, Soma M, Izumi Y, Kanmatsuse K (1996) Organization of the human prostacyclin synthase gene. Biochem Biophys Res Commun 221: 803–806PubMedCrossRefGoogle Scholar
  6. 6.
    Yokoyama C, Yabuki T, Inoue H, Tone Y, Hara S, Hatae T, Nagata M, Takahashi E-I, Tanabe T (1996) Human gene encoding prostacyclin synthase (PTGIS): genomic organization, chromosomal localization, and promoter activity. Genomics 36: 296–304PubMedCrossRefGoogle Scholar
  7. 7.
    Jones DA, Carlton DP, Mc Intyre TM, Zimmerman GA, Prescott SM (1993) Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268: 9049–9054PubMedGoogle Scholar
  8. 8.
    Laneuville O, Breuer DK, Xu N, Huang ZH, Gage DA, Watson JT, Lagarde M, De Witt DL, Smith WL (1995) Fatty acid substrate specificities of human prostaglandin endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z,13 E/Z, 15Z)-octadecatrienoic acids from 8-linolenic acid. J Biol Chem 270: 19330–19336PubMedCrossRefGoogle Scholar
  9. 9.
    Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D,Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC (1996) Structural basis for selective inhibition of ciclooxygenase-2 by antiinflammatory agents. Nature 384: 644648Google Scholar
  10. 10.
    Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF (1996) Flexibility of the NSAID binding site in the structure of human ciclooxygenase-2. Nature Struct Biol 3: 927–933PubMedCrossRefGoogle Scholar
  11. 11.
    Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231: 232–235PubMedGoogle Scholar
  12. 12.
    Smith WL, Lands WE (1971) Stimulation and blockade of prostaglandin biosynthesis. J Biol Chem 246: 6700–6702PubMedGoogle Scholar
  13. 13.
    Roth GJ, Malerus PW (1975) The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate protein fraction. J Clin Invest 56: 624–632Google Scholar
  14. 14.
    Patrignam P, Panara MR, Greco A, Fusco O, Natoli C, Iacobelli S, Cipollone F, Ganci A, Cremmon C, Maclouf J, Patrono C (1994) Biochemical and pharmacological characterization of the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 271: 1705–1712Google Scholar
  15. 15.
    Panara MR, Greco A, Santini G, Sciulli MG, Rotonda MT, Padovano R, di Giamberardino Met al (1995) Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-mtrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6(2,4-difluorothio-phenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthase. Br J Pharmacol 116:2429–2434PubMedGoogle Scholar

Copyright information

© Springer Verlag Italia, Milano 1999

Authors and Affiliations

  • A. Sala
  • R. Ballerio
  • S. Viappiani
  • S. Zarini

There are no affiliations available

Personalised recommendations